Half Year Trading Update
Victrex PLC
04 April 2008
4 April 2008
Victrex plc
Half Year Trading Update
The Company announces its trading update for the six months ended 31 March 2008.
Trading in the first half has continued in line with expectations. We have
achieved further sales growth, with record first half sales volume of
approximately 1,293 tonnes, some 6% ahead of the second half of last year (1,222
tonnes) and in line with the previous first half of 1,286 tonnes.
•United States volume showed continued growth at 418 tonnes which was 4%
ahead of last year's second half of 402 tonnes and 7% ahead of the previous
first half of 389 tonnes.
•European sales volume saw a return to growth at 646 tonnes, which was 10%
up on the second half of last year (587 tonnes) and close to the previous
first half (656 tonnes).
•Asia-Pacific sales volume was maintained at 229 tonnes, in line with the
second half of last year (233 tonnes) and 5% below the previous first half
(241 tonnes).
•At approximately £11.7m, revenues of Invibio(R), the medical implant
materials business, continued to show good growth, up by 19% on last year's
second half of £9.8m and by 23% on the previous first half of £9.5m.
The announcement of the Company's results for the six months ended 31 March 2008
will be made on Tuesday, 20 May 2008.
-Ends-
For further information please contact:
Victrex plc 01253 897700
Michael Peacock, Finance Director
Hogarth Partnership Limited 0207 357 9477
Nick Denton / Barnaby Fry
Victrex plc is an innovative, world leader in high performance materials through
the manufacture of VICTREX(R) PEEK(TM) polymer, a high performance, easy to
process thermoplastic.
VICTREX PEEK has a unique combination of chemical, wear, electrical, hydrolysis
and temperature resistance, as well as excellent dimensional, mechanical and
chemical stability combined with inherent purity and low flammability.
End users specify VICTREX PEEK to reduce systems costs, improve part
performance, exploit greater design freedom and create a differentiated
application. VICTREX PEEK is used across a broad range of applications in
diverse markets including transport, industrial, electronics and medical.
Invibio(R), Victrex's biomaterial business, provides specialised solutions for
medical device manufacturers.
The Group's headquarters are in the UK where its manufacturing facilities are
based. This is complemented by a global network of sales, distribution and
technical centres that serve more than 30 countries worldwide.
This information is provided by RNS
The company news service from the London Stock Exchange
Latest directors dealings
- 5 minutes ago Schroder Japan Growth Fund
- 26 minutes ago Schroder Income Growth Fund
- 28 minutes ago CVC Income & Growth Limited NPV GBP
- 30 minutes ago Schroder Japan Growth Fund
- 31 minutes ago SHAWBROOK GROUP PLC